Skip to content
OpenCapital
Get started

MGP Ingredients MGPI Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By segment

See full
Branded Spirits16%+23.1%
Ingredient Solutions14%+16.7%

Other financials

Income statement

See full
Revenue$106.4M-12.5%
Gross profit$33.6M-22.5%
Operating income-$173.2M-23,086%
Net income-$134.8M-4,358%
EPS (diluted)-$6.30-4,400%

Balance sheet

See full
Cash & equivalents$10.4M-48.5%
Total debt$260.4M-17.7%
Total equity$581.3M-29.8%
Total assets$1.0B-25.2%

Cash flow

See full
Operating cash flow$7.0M-84.4%
CapEx$5.7M-71.3%
Free cash flow$1.2M-95.0%

Valuation

See full
Market cap$349.42M-44.4%
Enterprise value$599.43M-35.1%
P/S0.7×-0.3×

Profitability

See full
Gross margin36.4%-4.4pp
Operating margin-51.2%—
Net margin-46%—
FCF margin10.2%+1.3pp

Returns & leverage

See full
Return on equity-34%—
Debt / equity0.4×+0.1×
Current ratio2.7×-0.1×